BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28843857)

  • 1. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma.
    Makita Y; Murata S; Katou Y; Kikuchi K; Uejima H; Teratani M; Hoashi Y; Kenjo E; Matsumoto S; Nogami M; Otake K; Kawamata Y
    Biochem Biophys Res Commun; 2017 Nov; 493(1):800-806. PubMed ID: 28843857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of kinetochore-associated protein 2 siRNA against lung cancer patient-derived tumor xenografts.
    Makita Y; Teratani M; Murata S; Hoashi Y; Matsumoto S; Kawamata Y
    Oncol Lett; 2018 Apr; 15(4):4676-4682. PubMed ID: 29541240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
    Guo Y; Wang J; Zhang L; Shen S; Guo R; Yang Y; Chen W; Wang Y; Chen G; Shuai X
    Hepatology; 2016 Apr; 63(4):1240-55. PubMed ID: 26680504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
    Rajasekaran D; Srivastava J; Ebeid K; Gredler R; Akiel M; Jariwala N; Robertson CL; Shen XN; Siddiq A; Fisher PB; Salem AK; Sarkar D
    Bioconjug Chem; 2015 Aug; 26(8):1651-61. PubMed ID: 26079152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis.
    Kaneko N; Miura K; Gu Z; Karasawa H; Ohnuma S; Sasaki H; Tsukamoto N; Yokoyama S; Yamamura A; Nagase H; Shibata C; Sasaki I; Horii A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1235-40. PubMed ID: 19878654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
    Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM
    Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.
    Hsu SH; Yu B; Wang X; Lu Y; Schmidt CR; Lee RJ; Lee LJ; Jacob ST; Ghoshal K
    Nanomedicine; 2013 Nov; 9(8):1169-80. PubMed ID: 23727126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
    Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
    Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma.
    Park JW; Lee YS; Kim JS; Lee SK; Kim BH; Lee JA; Lee NO; Kim SH; Hong EK
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1973-83. PubMed ID: 25842034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation.
    Huang XH; Jian WH; Wu ZF; Zhao J; Wang H; Li W; Xia JT
    Oncotarget; 2014 Jul; 5(14):5570-80. PubMed ID: 25015194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral-Mediated Short Hairpin RNA Knockdown of MTDH Inhibits Cell Growth and Induces Apoptosis by Regulating the PTEN/AKT Pathway in Hepatocellular Carcinoma.
    Li WF; Ou Q; Dai H; Liu CA
    Int J Mol Sci; 2015 Aug; 16(8):19419-32. PubMed ID: 26287185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.
    Futami K; Ogasawara S; Goto H; Yano H; Furuichi Y
    Int J Mol Med; 2010 Apr; 25(4):537-45. PubMed ID: 20198302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short interfering RNA-mediated gene silencing of SKA1 on proliferation of hepatocellular carcinoma cells.
    Qin X; Yuan B; Xu X; Huang H; Liu Y
    Scand J Gastroenterol; 2013 Nov; 48(11):1324-32. PubMed ID: 24010405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Nanoparticle Systems for Enabling Gene Therapies.
    Cullis PR; Hope MJ
    Mol Ther; 2017 Jul; 25(7):1467-1475. PubMed ID: 28412170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
    Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
    Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosis.
    Kornek M; Lukacs-Kornek V; Limmer A; Raskopf E; Becker U; Klöckner M; Sauerbruch T; Schmitz V
    Mol Med; 2008; 14(7-8):365-73. PubMed ID: 18392108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
    Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J
    Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
    Park MY; Park YS; Nam JH
    Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
    Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
    Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.